FDA's Crawford Open To Discussing Independent Drug Safety Office
This article was originally published in The Pink Sheet Daily
Executive Summary
Acting Commissioner Crawford tells members of the Senate Health Committee during his confirmation hearing that he is willing to talk about a more independent safety review office. However, the commissioner nominee also says the Office of Drug Safety already is "operating independently."